ISB Nabs $8M for Cancer Genome

Xconomy Seattle — 

The Institute for Systems Biology, a Seattle-based nonprofit research center, said today it has secured an $8 million grant from the National Institutes of Health as part of The Cancer Genome Atlas, an effort to identify new targets for cancer drugs based on deeper genomic understanding. ISB professor Ilya Shmulevich is the co-primary investigator on the grant along with Wei Zhang of M.D. Anderson Cancer Center in Houston. Other centers receiving federal grants for the cancer genome include the Broad Institute of Harvard and MIT; Lawrence Berkeley National Laboratory; and Memorial Sloan-Kettering Cancer Center.

By posting a comment, you agree to our terms and conditions.

Comments are closed.